Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in increased expression of ASB2 mRNA | CTD | PMID:22206623 | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of ASB2 mRNA | CTD | PMID:30723492 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Asb2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to ASB2 gene] | CTD | PMID:20819909 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of ASB2 mRNA | CTD | PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ASB2 mRNA | CTD | PMID:32109520 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ASB2 mRNA | CTD | PMID:20819909 and PMID:26290441 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ASB2 mRNA | CTD | PMID:20064835 more ... | 2,3,7,8-Tetrachlorodibenzofuran | decreases expression | EXP | | 6480464 | 2 more ... | CTD | PMID:32109520 | 2,4,6-trinitrotoluene | affects expression | EXP | | 6480464 | Trinitrotoluene affects the expression of ASB2 mRNA | CTD | PMID:21346803 | 4,4'-sulfonyldiphenol | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | bisphenol S results in increased expression of ASB2 mRNA | CTD | PMID:30951980 | 5-azacytidine | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Azacitidine results in increased expression of ASB2 mRNA | CTD | PMID:20823114 | aflatoxin B1 | decreases methylation | ISO | ASB2 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of ASB2 exon more ... | CTD | PMID:30157460 | Aflatoxin B2 alpha | increases methylation | ISO | ASB2 (Homo sapiens) | 6480464 | aflatoxin B2 results in increased methylation of ASB2 intron and aflatoxin B2 results in increased methylation of ASB2 promoter | CTD | PMID:30157460 | all-trans-retinoic acid | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of ASB2 mRNA | CTD | PMID:33167477 | aristolochic acid A | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of ASB2 mRNA | CTD | PMID:33212167 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of ASB2 mRNA | CTD | PMID:21839799 | benzo[a]pyrene | affects methylation | ISO | ASB2 (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of ASB2 3' UTR and Benzo(a)pyrene affects the methylation of ASB2 intron | CTD | PMID:27901495 and PMID:30157460 | benzo[a]pyrene | increases methylation | ISO | ASB2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of ASB2 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of ASB2 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | multiple interactions | ISO | ASB2 (Homo sapiens) | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene results in increased expression of ASB2 mRNA] | CTD | PMID:20064835 | benzo[b]fluoranthene | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | benzo(b)fluoranthene results in decreased expression of ASB2 mRNA | CTD | PMID:26377693 | benzo[e]pyrene | increases methylation | ISO | ASB2 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of ASB2 intron and benzo(e)pyrene results in increased methylation of ASB2 promoter | CTD | PMID:30157460 | bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of ASB2 mRNA | CTD | PMID:25181051 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of ASB2 mRNA | CTD | PMID:32145629 and PMID:34947998 | bisphenol A | increases methylation | EXP | | 6480464 | bisphenol A results in increased methylation of ASB2 gene | CTD | PMID:28505145 | bisphenol F | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | bisphenol F results in increased expression of ASB2 mRNA | CTD | PMID:30951980 | butanal | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | butyraldehyde results in increased expression of ASB2 mRNA | CTD | PMID:26079696 | cannabidiol | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | Cannabidiol results in increased expression of ASB2 mRNA | CTD | PMID:27256343 | cantharidin | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | Cantharidin results in decreased expression of ASB2 mRNA | CTD | PMID:36907384 | chlorpyrifos | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of ASB2 mRNA | CTD | PMID:32715474 | cisplatin | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of ASB2 mRNA | CTD | PMID:27594783 | cobalt atom | multiple interactions | ISO | ASB2 (Homo sapiens) | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of ASB2 mRNA | CTD | PMID:20105288 | cobalt dichloride | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of ASB2 mRNA | CTD | PMID:20105288 | copper atom | increases expression | EXP | | 6480464 | Copper results in increased expression of ASB2 mRNA | CTD | PMID:30556269 | copper(0) | increases expression | EXP | | 6480464 | Copper results in increased expression of ASB2 mRNA | CTD | PMID:30556269 | copper(II) sulfate | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Copper Sulfate results in increased expression of ASB2 mRNA | CTD | PMID:19549813 | cyclosporin A | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of ASB2 mRNA | CTD | PMID:25562108 | dexamethasone | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | Dexamethasone results in increased expression of ASB2 mRNA | CTD | PMID:22733784 | dextran sulfate | multiple interactions | ISO | Asb2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ASB2 mRNA | CTD | PMID:29950665 | dichloroacetic acid | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | Dichloroacetic Acid results in decreased expression of ASB2 mRNA | CTD | PMID:28962523 | diuron | decreases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Diuron results in decreased expression of ASB2 mRNA | CTD | PMID:35967413 | doxorubicin | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | Doxorubicin results in decreased expression of ASB2 mRNA | CTD | PMID:25896364 | doxorubicin | affects expression | ISO | ASB2 (Homo sapiens) | 6480464 | Doxorubicin affects the expression of ASB2 mRNA | CTD | PMID:29803840 | fenthion | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | Fenthion results in decreased expression of ASB2 mRNA | CTD | PMID:34813904 | genistein | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | Genistein results in increased expression of ASB2 mRNA | CTD | PMID:32186404 | GW 4064 | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | GW 4064 results in increased expression of ASB2 mRNA | CTD | PMID:26655953 | hexadecanoic acid | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Palmitic Acid results in increased expression of ASB2 mRNA | CTD | PMID:32347412 | irinotecan | affects expression | EXP | | 6480464 | Irinotecan affects the expression of ASB2 mRNA | CTD | PMID:20097248 | lead(0) | decreases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Lead results in decreased expression of ASB2 mRNA | CTD | PMID:19921347 | methapyrilene | increases methylation | ISO | ASB2 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of ASB2 intron and Methapyrilene results in increased methylation of ASB2 promoter | CTD | PMID:30157460 | methidathion | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | methidathion results in decreased expression of ASB2 mRNA | CTD | PMID:34813904 | Muraglitazar | increases expression | EXP | | 6480464 | muraglitazar results in increased expression of ASB2 mRNA | CTD | PMID:21515302 | N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of ASB2 mRNA | CTD | PMID:25566086 | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of ASB2 mRNA | CTD | PMID:33484710 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of ASB2 mRNA | CTD | PMID:25729387 | oxaliplatin | increases expression | EXP | | 6480464 | oxaliplatin results in increased expression of ASB2 mRNA | CTD | PMID:25729387 | ozone | multiple interactions | ISO | Asb2 (Mus musculus) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which results in decreased expression of ASB2 mRNA | CTD | PMID:34911549 | ozone | multiple interactions | ISO | ASB2 (Homo sapiens) | 6480464 | [Air Pollutants results in increased abundance of Ozone] which affects the expression of ASB2 mRNA | CTD | PMID:35430440 | pentanal | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | pentanal results in increased expression of ASB2 mRNA | CTD | PMID:26079696 | progesterone | multiple interactions | ISO | ASB2 (Homo sapiens) | 6480464 | [Progesterone co-treated with TGFB1 protein] results in increased expression of ASB2 mRNA | CTD | PMID:21768398 | progesterone | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Progesterone results in increased expression of ASB2 mRNA | CTD | PMID:21768398 | propanal | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | propionaldehyde results in increased expression of ASB2 mRNA | CTD | PMID:26079696 | quercetin | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Quercetin results in increased expression of ASB2 mRNA | CTD | PMID:21632981 | rotenone | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Rotenone results in increased expression of ASB2 mRNA | CTD | PMID:29955902 | rotenone | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | Rotenone results in increased expression of ASB2 mRNA | CTD | PMID:32937126 | silicon dioxide | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Silicon Dioxide analog results in increased expression of ASB2 mRNA | CTD | PMID:25895662 | sulforaphane | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | sulforaphane results in increased expression of ASB2 mRNA | CTD | PMID:30529165 | tamibarotene | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | tamibarotene results in increased expression of ASB2 mRNA | CTD | PMID:17229644 | Tesaglitazar | increases expression | EXP | | 6480464 | tesaglitazar results in increased expression of ASB2 mRNA | CTD | PMID:21515302 | tetrachloroethene | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | Tetrachloroethylene results in decreased expression of ASB2 mRNA | CTD | PMID:28973375 | titanium dioxide | decreases expression | ISO | Asb2 (Mus musculus) | 6480464 | titanium dioxide results in decreased expression of ASB2 mRNA | CTD | PMID:23557971 | titanium dioxide | multiple interactions | ISO | Asb2 (Mus musculus) | 6480464 | [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of ASB2 mRNA | CTD | PMID:29950665 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in increased expression of ASB2 mRNA | CTD | PMID:25729387 | topotecan | increases expression | EXP | | 6480464 | Topotecan results in increased expression of ASB2 mRNA | CTD | PMID:25729387 | trichostatin A | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of ASB2 mRNA | CTD | PMID:24935251 | triclosan | decreases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Triclosan results in decreased expression of ASB2 mRNA | CTD | PMID:30510588 | trimellitic anhydride | increases expression | ISO | Asb2 (Mus musculus) | 6480464 | trimellitic anhydride results in increased expression of ASB2 mRNA | CTD | PMID:19042947 | tris(2-butoxyethyl) phosphate | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | tris(2-butoxyethyl) phosphate results in increased expression of ASB2 mRNA | CTD | PMID:29024780 | troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of ASB2 mRNA | CTD | PMID:21515302 | Tungsten carbide | multiple interactions | ISO | ASB2 (Homo sapiens) | 6480464 | [tungsten carbide binds to Cobalt] which results in increased expression of ASB2 mRNA | CTD | PMID:20105288 | urethane | decreases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Urethane results in decreased expression of ASB2 mRNA | CTD | PMID:28818685 | valproic acid | increases methylation | ISO | ASB2 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of ASB2 gene | CTD | PMID:29154799 | valproic acid | increases expression | ISO | ASB2 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of ASB2 mRNA | CTD | PMID:28001369 | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of ASB2 mRNA | CTD | PMID:23034163 | |